{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T05:58:39Z","timestamp":1774159119205,"version":"3.50.1"},"reference-count":127,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Research Foundation","award":["CH 806\/1-1"],"award-info":[{"award-number":["CH 806\/1-1"]}]},{"name":"German Research Foundation","award":["HI 1837\/1-1"],"award-info":[{"award-number":["HI 1837\/1-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Autoimmune hepatitis (AIH) is characterized by a progressive destruction of the liver parenchyma and a chronic fibrosis. The current treatment of autoimmune hepatitis is still largely dependent on the administration of corticosteroids and cytostatic drugs. For a long time the development of novel therapeutic strategies has been hampered by a lack of understanding the basic immunopathogenic mechanisms of AIH and the absence of valid animal models. However, in the past decade, knowledge from clinical observations in AIH patients and the development of innovative animal models have led to a situation where critical factors driving the disease have been identified and alternative treatments are being evaluated. Here we will review the insight on the immunopathogenesis of AIH as gained from clinical observation and from animal models.<\/jats:p>","DOI":"10.3390\/ijms17122007","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T10:36:37Z","timestamp":1480674997000},"page":"2007","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-7976","authenticated-orcid":false,"given":"Urs","family":"Christen","sequence":"first","affiliation":[{"name":"Pharmazentrum Frankfurt\/ZAFES, Goethe University Hospital, Theodor-Stern Kai 7, 60590 Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Hintermann","sequence":"additional","affiliation":[{"name":"Pharmazentrum Frankfurt\/ZAFES, Goethe University Hospital, Theodor-Stern Kai 7, 60590 Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","author":"Czaja","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: A comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"14","author":"Vierling","year":"2012","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bpg.2011.10.004","article-title":"Diagnostic criteria for autoimmune hepatitis","volume":"25","author":"Lohse","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2014Update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","article-title":"Prevalence and epidemiology of autoimmune hepatitis","volume":"6","author":"Boberg","year":"2002","journal-title":"Clin. Liver Dis."},{"key":"ref_7","first-page":"55","article-title":"Autoimmune hepatitis\u2014Approach to diagnosis","volume":"8","author":"Czaja","year":"2006","journal-title":"MedGenMed"},{"key":"ref_8","unstructured":"World Health Organization. Dept. of Protection of the Human Environment, and Inter-Organization Programme for the Sound Management of Chemicals Principles and Methods for Assessing Autoimmunity Associated with Exposure to Chemicals. Available online: http:\/\/www.who.int\/iris\/handle\/10665\/43603."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840190311","article-title":"Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis","volume":"19","author":"Doherty","year":"1994","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: Immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","article-title":"Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients","volume":"40","author":"Renous","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J. Autoimmun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"Zwiers","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: Clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"Zwiers","year":"2015","journal-title":"Genes Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1155\/2013\/981086","article-title":"Challenges in the diagnosis and management of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bpg.2011.08.003","article-title":"Therapy of autoimmune hepatitis","volume":"25","author":"Strassburg","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/imt.13.5","article-title":"The role of autoantibodies in autoimmune hepatitis type 2","volume":"5","author":"Christen","year":"2013","journal-title":"Immunotherapy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/eji.1830230519","article-title":"Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)","volume":"23","author":"Yamamoto","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.1991.tb08164.x","article-title":"Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis","volume":"84","author":"Lohr","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.510240619","article-title":"Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis","volume":"24","author":"Lohr","year":"1996","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10620-012-2151-2","article-title":"Advances in the current treatment of autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Schramm","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can. J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0676.1987.tb00361.x","article-title":"Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage","volume":"7","author":"Vergani","year":"1987","journal-title":"Liver"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.46.4.553","article-title":"Liver\/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane","volume":"46","author":"Muratori","year":"2000","journal-title":"Gut"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4049\/jimmunol.1600089","article-title":"Features of Human CD3+CD20+ T Cells","volume":"197","author":"Schuh","year":"2016","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/adc.67.12.1447","article-title":"Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis","volume":"67","author":"Senaldi","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"ref_44","first-page":"16","article-title":"Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis","volume":"38","author":"Vergani","year":"1979","journal-title":"Clin. Exp. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0140-6736(90)93306-A","article-title":"T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis","volume":"336","author":"Wen","year":"1990","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","author":"Hintermann","year":"2011","journal-title":"J. Autoimmun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhao, L., Tang, Y., You, Z., Wang, Q., Liang, S., Han, X., Qiu, D., Wei, J., Liu, Y., and Shen, L. (2011). Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018909"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nri2660","article-title":"Interplay between the TH17 and TReg cell lineages: A (co-)evolutionary perspective","volume":"9","author":"Weaver","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.22914","article-title":"Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells","volume":"50","author":"Longhi","year":"2009","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12016-013-8383-x","article-title":"Autoimmune features in metabolic liver disease: A single-center experience and review of the literature","volume":"45","author":"Tsuneyama","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00535-005-1711-z","article-title":"Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: Is the International Autoimmune Hepatitis Group scoring system useful?","volume":"40","author":"Yatsuji","year":"2005","journal-title":"J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"893026","DOI":"10.1155\/2012\/893026","article-title":"Role of adaptive immunity in alcoholic liver disease","volume":"2012","author":"Albano","year":"2012","journal-title":"Int. J. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2016.02.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model","volume":"69","author":"Muller","year":"2016","journal-title":"J. Autoimmun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0300-483X(94)03010-Y","article-title":"Molecular mimicry in halothane hepatitis: Biochemical and structural characterization of lipoylated autoantigens","volume":"97","author":"Gut","year":"1995","journal-title":"Toxicology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: Identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0092-8674(87)90507-1","article-title":"Molecular mimicry and autoimmune disease","volume":"50","author":"Oldstone","year":"1987","journal-title":"Cell"},{"key":"ref_63","unstructured":"Shoenfeld, Y., Meroni, P.L., and Gershwin, M.E. (2014). Autoantibodies, Elsevier. [3rd ed.]."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/08830185.2014.921162","article-title":"Pathogen infection as a possible cause for autoimmune hepatitis","volume":"33","author":"Christen","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: A case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6193\u2013212: A new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/08830185.2014.897345","article-title":"Pathogen infection and autoimmunity","volume":"33","author":"Christen","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/jir.2013.0075","article-title":"Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis","volume":"34","author":"Landi","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1517\/14656566.2014.931938","article-title":"Current and prospective pharmacotherapy for autoimmune hepatitis","volume":"15","author":"Czaja","year":"2014","journal-title":"Expert Opin. Pharm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2249.2001.01391.x","article-title":"Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes","volume":"123","author":"Nishioji","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"ref_72","first-page":"299","article-title":"Investigate circulating levels of chemokines and evaluate the correlation between these chemokines and liver function indicators in autoimmune hepatitis","volume":"21","author":"Li","year":"2013","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.27087","article-title":"Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice","volume":"60","author":"Ikeda","year":"2014","journal-title":"Hepatology"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Parnham, M. (2015). Encyclopedia of Inflammatory Diseases, Springer.","DOI":"10.1007\/978-3-0348-0620-6"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/iep.12090","article-title":"Hepatitis mouse models: From acute-to-chronic autoimmune hepatitis","volume":"95","author":"Yuksel","year":"2014","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2174\/1381612821666150316121319","article-title":"An update on animal models of autoimmune hepatitis: Are we there yet?","volume":"21","author":"Christen","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_77","first-page":"99","article-title":"Experimental chronic active hepatitis in rabbits following immunization with human liver proteins","volume":"11","author":"Kossling","year":"1972","journal-title":"Clin. Exp. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0016-5085(83)90085-9","article-title":"Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae","volume":"84","author":"Kuriki","year":"1983","journal-title":"Gastroenterology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"ref_80","first-page":"105","article-title":"Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice","volume":"67","author":"Watanabe","year":"1987","journal-title":"Clin. Exp. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.510270611","article-title":"Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression","volume":"27","author":"Lohse","year":"1998","journal-title":"Hepatology"},{"key":"ref_83","first-page":"1","article-title":"Breeding of a non-obese, diabetic strain of mice","volume":"29","author":"Makino","year":"1980","journal-title":"Jikken Dobutsu"},{"key":"ref_84","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am. J. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.gastro.2013.03.011","article-title":"Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis","volume":"145","author":"Maruoka","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Qi, N., Liu, P., Zhang, Y., Wu, H., Chen, Y., and Han, D. (2013). Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking Tyro3, Axl and Mer receptor tyrosine kinases. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066604"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A.","volume":"90","author":"Tiegs","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","article-title":"Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A","volume":"111","author":"Kusters","year":"1996","journal-title":"Gastroenterology"},{"key":"ref_90","first-page":"190","article-title":"Concanavalin A-induced T-cell-mediated hepatic injury in mice: The role of tumor necrosis factor","volume":"21","author":"Gantner","year":"1995","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/excr.1996.0351","article-title":"T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release","volume":"229","author":"Gantner","year":"1996","journal-title":"Exp. Cell Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.152.7.3245","article-title":"Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo","volume":"152","author":"Ando","year":"1994","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1691527","article-title":"Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice","volume":"248","author":"Moriyama","year":"1990","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.8303275","article-title":"Levels of peripheral T cell tolerance induced by different doses of tolerogen","volume":"263","author":"Ferber","year":"1994","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D","article-title":"Failure to induce organ-specific autoimmunity by breaking of tolerance: Importance of the microenvironment","volume":"28","author":"Limmer","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.165.5.2415","article-title":"Break of T cell ignorance to a viral antigen in the liver induces hepatitis","volume":"165","author":"Voehringer","year":"2000","journal-title":"J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1002\/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E","article-title":"CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes","volume":"32","author":"Sacher","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.4049\/jimmunol.169.9.4889","article-title":"DNA vaccination breaks tolerance for a neo-self antigen in liver: A transgenic murine model of autoimmune hepatitis","volume":"169","author":"Lapierre","year":"2002","journal-title":"J. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clim.2005.08.010","article-title":"Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12","volume":"117","author":"Tamaki","year":"2005","journal-title":"Clin. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/hep.21796","article-title":"Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis","volume":"46","author":"Derkow","year":"2007","journal-title":"Hepatology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2010.05.075","article-title":"Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis","volume":"139","author":"Zierden","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrmicro754","article-title":"Microorganisms and autoimmunity: Making the barren field fertile","volume":"1","author":"Fujinami","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(91)90164-T","article-title":"Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice","volume":"65","author":"Ohashi","year":"1991","journal-title":"Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1074-7613(94)90101-5","article-title":"How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model","volume":"1","author":"Dockter","year":"1994","journal-title":"Immunity"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/BOR.0b013e3283533719","article-title":"Infection as a cause of type 1 diabetes?","volume":"24","author":"Christen","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI200421593","article-title":"The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity","volume":"114","author":"Bowen","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri981","article-title":"Hepatic T cells and liver tolerance","volume":"3","author":"Crispe","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_112","first-page":"3403","article-title":"Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs","volume":"118","author":"Luth","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.21379","article-title":"In vivo immune modulatory activity of hepatic stellate cells in mice","volume":"44","author":"Chen","year":"2006","journal-title":"Hepatology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2008-05-159921","article-title":"Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance","volume":"112","author":"Xia","year":"2008","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/ijms16011980","article-title":"Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: Novel perspective from a new mouse model","volume":"16","author":"Alexandropoulos","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hep.27639","article-title":"Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens","volume":"61","author":"Taubert","year":"2015","journal-title":"Hepatology"},{"key":"ref_117","first-page":"1","article-title":"The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice","volume":"60","author":"Hintermann","year":"2012","journal-title":"J. Vis. Exp."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","article-title":"Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51","volume":"17","author":"Bogdanos","year":"2004","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0896-8411(91)90180-K","article-title":"Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody","volume":"4","author":"Gueguen","year":"1991","journal-title":"J. Autoimmun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/jaut.2001.0565","article-title":"Differences in Anti-LKM-1 Autoantibody Immunoreactivity to CYP2D6 Antigenic Sites Between Hepatitis C Virus-negative and -positive Patients","volume":"17","author":"Kitazawa","year":"2001","journal-title":"J. Autoimmun."},{"key":"ref_122","unstructured":"Ehser, J., M\u00fcller, P., Bayer, M., Pfeilschifter, J.M., Hintermann, E., and Christen, U. (2016). Absence of CXCL10 or CCL5 has opposite effects on the severity of autoimmune hepatitis in the CYP2D6 mouse model. Unpublished work."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1478-3231.2009.02028.x","article-title":"The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis","volume":"29","author":"Milks","year":"2009","journal-title":"Liver Int."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.1003750","article-title":"CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis","volume":"186","author":"Erhardt","year":"2011","journal-title":"J. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1128\/MCB.00556-06","article-title":"CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis","volume":"26","author":"Colvin","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2013.05.001","article-title":"Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6","volume":"44","author":"Hintermann","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/hep.26380","article-title":"Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells","volume":"58","author":"Fischer","year":"2013","journal-title":"Hepatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/12\/2007\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:27:48Z","timestamp":1760210868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/12\/2007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":127,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["ijms17122007"],"URL":"https:\/\/doi.org\/10.3390\/ijms17122007","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}